Brief: Cytodyn Inc. Announces Positive Preliminary Results Of Unblinded Data From Long-Haulers Trial Showing Greater Improvement In Leronlimab Group Over Placebo In 18 Of 24 Symptoms
21/06/2021 13:36
June 21 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN INC. ANNOUNCES POSITIVE PRELIMINARY RESULTS OF
UNBLINDED
DATA FROM LONG-HAULERS TRIAL SHOWING GREATER IMPROVEMENT IN
LERONLIMAB GROUP OVER PLACEBO IN 18 OF 24 SYMPTOMS
Source text for Eikon: ID:nGNXc0k3mB
Further company coverage: CYDY.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer